Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded by Columbia alumni, Sonnerie VC is a pre-seed venture capital fund based in New York. The firm specializes in U.S. healthcare and technology startups, particularly in regulated markets. It leverages the general partners' experience from a strategic exit valued at $1.3 billion.
Sonnerie VC invests in early-stage healthcare and technology companies, specifically targeting those facing commercialization and compliance barriers. The fund typically engages with startups at the pre-seed and seed stages, providing capital and operational insights to help scale their businesses.
Notable portfolio company includes BMI OrganBank, which is developing advanced organ perfusion and preservation technology to enhance transplant access and improve patient outcomes.
Submit through their form at sonnerievc.com or email info@sonnerievc.com with your deck.
Yes, Sonnerie VC often leads investment rounds, particularly in the pre-seed and seed stages.
Sonnerie VC is open to follow-on investments, especially for companies that demonstrate significant growth and potential in their sectors.
The specific size of Sonnerie VC's current fund is not disclosed, but it focuses on early-stage investments in healthcare and technology.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.